HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
THURSDAY, May 5, 2022 (HealthDay News) -- The risk for developing obesity is higher among adults with versus without asthma, according to a study published online April 27 in Thorax.
Subhabrata Moitra, Ph.D., from University of Alberta in Edmonton, Canada, and colleagues used data from three waves of the European Community Respiratory Health Survey (1990 to 2014) to assess the link between asthma and obesity. The analysis included data for 7,576 adults.
The researchers found that the risk for developing obesity was higher among adults with asthma than adults without asthma (relative risk, 1.22 [95 percent confidence interval, 1.07 to 1.38). Risk was particularly high among those with nonatopic versus atopic disease (relative risk, 1.47 [1.17 to 1.86] versus 1.04 [0.86 to 1.27]), those with longer disease duration (relative risk, 1.32 [1.10 to 1.59] in >20 years versus 1.12 [0.87 to 1.43] in ≤20 years), and those on oral corticosteroids (relative risk, 1.99 [1.26 to 3.15] versus 1.15 [1.03 to 1.28]). This association was not mediated by physical activity.
"Understanding the crosstalk between asthma and obesity would help set a proper strategy for asthma management, particularly with an emphasis on reducing adverse effects of corticosteroids in asthma treatment," the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on May 25, 2022